Vanguard Group
TCRT icon

Vanguard Group’s Alaunos Therapeutics TCRT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$102K Hold
20,972
﹤0.01% 4148
2025
Q1
$30.4K Hold
20,972
﹤0.01% 4225
2024
Q4
$39.8K Sell
20,972
-24,376
-54% -$46.3K ﹤0.01% 4225
2024
Q3
$149K Sell
45,348
-583,800
-93% -$1.92M ﹤0.01% 4165
2024
Q2
$440K Hold
629,148
﹤0.01% 4043
2024
Q1
$1.14M Sell
629,148
-8,809,614
-93% -$15.9M ﹤0.01% 3767
2023
Q4
$667K Hold
9,438,762
﹤0.01% 3950
2023
Q3
$1.24M Buy
9,438,762
+327,078
+4% +$43.1K ﹤0.01% 3755
2023
Q2
$4.65M Sell
9,111,684
-44,057
-0.5% -$22.5K ﹤0.01% 3343
2023
Q1
$5.77M Buy
9,155,741
+8,000
+0.1% +$5.04K ﹤0.01% 3232
2022
Q4
$5.94M Sell
9,147,741
-14,782
-0.2% -$9.6K ﹤0.01% 3221
2022
Q3
$15.8M Sell
9,162,523
-133,332
-1% -$229K ﹤0.01% 2739
2022
Q2
$11.5M Sell
9,295,855
-1,482,815
-14% -$1.84M ﹤0.01% 2917
2022
Q1
$7.03M Sell
10,778,670
-855,030
-7% -$558K ﹤0.01% 3339
2021
Q4
$12.7M Sell
11,633,700
-752,133
-6% -$820K ﹤0.01% 3094
2021
Q3
$22.5M Sell
12,385,833
-3,391,633
-21% -$6.17M ﹤0.01% 2803
2021
Q2
$41.7M Sell
15,777,466
-269,988
-2% -$713K ﹤0.01% 2468
2021
Q1
$57.8M Buy
16,047,454
+78,033
+0.5% +$281K ﹤0.01% 2236
2020
Q4
$40.2M Buy
15,969,421
+685,985
+4% +$1.73M ﹤0.01% 2317
2020
Q3
$38.5M Sell
15,283,436
-201,250
-1% -$507K ﹤0.01% 2140
2020
Q2
$50.8M Buy
15,484,686
+328,363
+2% +$1.08M ﹤0.01% 2004
2020
Q1
$37.1M Buy
15,156,323
+2,561,312
+20% +$6.28M ﹤0.01% 2000
2019
Q4
$59.4M Buy
12,595,011
+1,422,738
+13% +$6.72M ﹤0.01% 2019
2019
Q3
$47.8M Sell
11,172,273
-82,455
-0.7% -$353K ﹤0.01% 2094
2019
Q2
$65.6M Buy
11,254,728
+1,167,963
+12% +$6.81M ﹤0.01% 1962
2019
Q1
$38.8M Buy
10,086,765
+4,503,784
+81% +$17.3M ﹤0.01% 2217
2018
Q4
$10.4M Sell
5,582,981
-3,200,715
-36% -$5.99M ﹤0.01% 2758
2018
Q3
$28.1M Buy
8,783,696
+194,441
+2% +$622K ﹤0.01% 2420
2018
Q2
$25.9M Buy
8,589,255
+159,136
+2% +$481K ﹤0.01% 2451
2018
Q1
$33M Sell
8,430,119
-62,246
-0.7% -$244K ﹤0.01% 2285
2017
Q4
$35.2M Buy
8,492,365
+305,219
+4% +$1.26M ﹤0.01% 2244
2017
Q3
$50.3M Buy
8,187,146
+322,676
+4% +$1.98M ﹤0.01% 2040
2017
Q2
$48.9M Buy
7,864,470
+553,933
+8% +$3.45M ﹤0.01% 2028
2017
Q1
$46.3M Buy
7,310,537
+396,678
+6% +$2.51M ﹤0.01% 2046
2016
Q4
$37M Buy
6,913,859
+194,798
+3% +$1.04M ﹤0.01% 2122
2016
Q3
$37.8M Sell
6,719,061
-7,255
-0.1% -$40.8K ﹤0.01% 2062
2016
Q2
$36.9M Buy
6,726,316
+154,404
+2% +$848K ﹤0.01% 2032
2016
Q1
$48.8M Buy
6,571,912
+181,484
+3% +$1.35M ﹤0.01% 1871
2015
Q4
$53.1M Buy
6,390,428
+1,975,303
+45% +$16.4M ﹤0.01% 1856
2015
Q3
$39.8M Buy
4,415,125
+204,562
+5% +$1.84M ﹤0.01% 1979
2015
Q2
$50.5M Buy
4,210,563
+1,070,086
+34% +$12.8M ﹤0.01% 1943
2015
Q1
$33.8M Buy
3,140,477
+418,423
+15% +$4.51M ﹤0.01% 2106
2014
Q4
$13.8M Buy
2,722,054
+33,647
+1% +$171K ﹤0.01% 2406
2014
Q3
$7.1M Sell
2,688,407
-167,530
-6% -$442K ﹤0.01% 2657
2014
Q2
$11.5M Buy
2,855,937
+317,044
+12% +$1.28M ﹤0.01% 2443
2014
Q1
$11.6M Buy
2,538,893
+108,900
+4% +$499K ﹤0.01% 2411
2013
Q4
$10.5M Buy
2,429,993
+362,229
+18% +$1.57M ﹤0.01% 2435
2013
Q3
$8.17M Buy
2,067,764
+236,387
+13% +$934K ﹤0.01% 2491
2013
Q2
$3.85M Buy
+1,831,377
New +$3.85M ﹤0.01% 2801